I was amazed by a few aspects of the article.
The drug does not seem very effective for its target "problem".
It seems likely to be prescribed "off label" for other uses.
It's an expensive treatment, of dubious benefit, may not be fit for the use intended and may even get prescribed to treat conditions outside it target.
Just how low is the bar these days in the pharmaceutical industry?